CXCL13 and pancreatic ductal adenocarcinoma: Furthermore, CXCL13 increases the expression of EVT4 in pancreatic ductal adenocarcinoma (PDAC), and EVT4 promotes PDAC invasion and metastasis by binding to CXCR5 on the tumor cell surface (35).